Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
PaperCitations, authors & open-access status
Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 423 citations, 2018 year and bronze oa status.
423
Citations
2018
Year
bronze
OA Status